David Mörtsell
31 – 33 of 33
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- 4
- next »
- 2013
-
Mark
Markers of inflammation, endothelial activation, and arterial stiffness in hypertensive heart disease and the effects of treatment : results from the SILVHIA study
Jekell, Andreas ; Malmqvist, Karin ; Wallén, N Håkan ; Mörtsell, David LU
and Kahan, Thomas
(2013)
In Journal of Cardiovascular Pharmacology
62(6).
p.66-559
- Contribution to journal › Article
- 2011
-
Mark
Permanent pacemaker implantation early and late after heart transplantation : clinical indication, risk factors and prognostic implications
Jones, David G ; Mortsell, David H LU
; Rajaruthnam, Direndra
; Hamour, Iman
; Hussain, Wajid
; Markides, Vias
; Banner, Nicholas R
and Wong, Tom
(2011)
In The Journal of Heart and Lung Transplantation
30(11).
p.65-1257
- Contribution to journal › Article
- 2007
-
Mark
Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study
Mörtsell, David LU
; Malmqvist, Karin
; Held, Claes
and Kahan, Thomas
(2007)
In Journal of Internal Medicine
261(5).
p.472-479
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- 4
- next »